Eli Lilly | Fremdkapital



Loan Capital Veränderung Datum
AbbVie USD 64.53B 4.19B 2025-03
Abbott USD 12.93B 194M 2025-06
ALKERMES USD 0 0 2025-03
Amgen USD 53.76B 253M 2025-06
AstraZeneca USD 25.99B 1.9B 2025-06
Baxter International USD 9.41B 962M 2025-03
Biogen USD 6.28B 1.74B 2025-06
Bristol-Myers Squibb USD 44.47B 1.69B 2025-06
Drreddys Laboratories INR 7.58B 218M 2024-12
Eli Lilly USD 34.18B 319.4M 2025-06
Gilead Sciences USD 22.14B 6M 2025-06
GlaxoSmithKline GBP 15.3B 1.17B 2025-06
Glaxosmithkline GBP 14.64B 1.39B 2024-12
J&J USD 38.36B 7.7B 2025-03
Medtronic USD 25.64B 1.66B 2025-04
Merck USD 33.97B 484M 2025-06
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 24.06B 2.4B 2025-06
Novartis USD 22.93B 2.41B 2024-12
Novo Nordisk 87.3B 9.01B 2025-06
Perrigo USD 3.62B 24.2M 2025-06
Pfizer USD 57.5B 137M 2025-06
Prestige Brands USD 1.01B 256K 2025-06
Regeneron Pharmaceuticals USD 1.99B 719.7M 2025-06
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 13.2B 211M 2025-06
Sanofi 11.79B 712M 2024-12
United Therapeutics USD 0 0 2025-03
Zoetis USD 5.23B 4M 2025-06


Eli Lilly Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.